Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease
Main Authors: | Naim Shehadeh, Itamar Raz, Afif Nakhleh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12933-018-0760-6 |
Similar Items
-
The level of glycemia as a risk factor of cardiovascular diseases
by: Ashot Musaelovich Mkrtumyan
Published: (2010-09-01) -
Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies
by: Nawfal Hasan Siam, et al.
Published: (2024-12-01) -
Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia
by: Keita Suzuki, et al.
Published: (2023-02-01) -
Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes
by: Melanie J. Davies, et al.
Published: (2022-08-01) -
The Association between DASH Diet Adherence and Cardiovascular Risk Factors
by: Nargeskhatoon Shoaibinobarian, et al.
Published: (2023-02-01)